e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
To compare the incomparable: COVID-19 pneumonia and high-altitude disease
Giacomo Strapazzon, Matthias P. Hilty, Pierre Bouzat, Lorenza Pratali, Hermann Brugger, Simon Rauch
Source:
Eur Respir J, 55 (6) 2001362; 10.1183/13993003.01362-2020
Journal Issue:
June
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Giacomo Strapazzon, Matthias P. Hilty, Pierre Bouzat, Lorenza Pratali, Hermann Brugger, Simon Rauch. To compare the incomparable: COVID-19 pneumonia and high-altitude disease. Eur Respir J, 55 (6) 2001362; 10.1183/13993003.01362-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
High-altitude pulmonary hypertension: a pathophysiological entity to different diseases
Source: Eur Respir J 2003 Dec 01;22(6):1019-1025
Year: 2003
The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003
Late-breaking abstract: Comparison of respiratory symptoms in chronic pulmonary obstructive disease and restrictive ventilatory impairment according to disease stage: The PLATINO study in Latin America
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011
The comparisons of severity scoring systems for community acquired pneumonia patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006
GBD 2017 estimates on asthma, COPD and other: challenges to measure respiratory disease worldwide
Source: International Congress 2019 – The Global Burden of Disease, Global Alliance for Chronic Diseases and Forum of International Respiratory Societies and other international initiatives
Year: 2019
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
An outbreak of pneumococcal-chlamydial pneumonia and acute respiratory disease (ARD) among trainees
Source: Eur Respir J 2001; 18: Suppl. 33, 464s
Year: 2001
Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Potential misclassification of causes of death from COPD
Source: Eur Respir J 2006 Oct 01;28(4):781-785
Year: 2006
Fungal VAP
Source: Eur Respir Mon 2011; 53: 122-137
Year: 2011
Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
Prevalence of chronic obstructive pulmonary disease in a western Norwegian community - a comparison of spirometric disease criteria
Source: Eur Respir J 2004; 24: Suppl. 48, 358s
Year: 2004
Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012
COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept